| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | B |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C8,10,13, |
| Comment | C |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Alkaline phosphatase (ALP), liver type |
| Unit | U / L |
| Overall Analytical Principle Method | Enzymatic analysis - IFCC method |
| Number of Subjects | 10 |
| Number of Subjects included in BV estimation | 10 |
| Ethinicity | Caucasian |
| Age Mean / Median | |
| Age Min | 25.0 |
| Age Max | 50.0 |
| Age SD | |
| Number of Males | 5 |
| Number of Females | 5 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 30 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
08
End Time: 09:00 |
| Number of Samples | 4 |
| Average Number of Samples Used for BV Estimation | 4.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 6.0 |
| Calculated Confidence Intervals of CVi | Lower: 4.73, Upper: 8.10 |
| Estimates of CVg | 21.0 |
| Calculated Confidence Intervals of CVg | Lower: 14.50, Upper: 37.11 |
| Analytical CV | 1.8 |
| Calculated Confidence Intervals of Analytical CV | Lower: 1.48, Upper: 2.30 |
| Measurand Mean | 62.0 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |